Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

A legfontosabb adatok

Ki végzi
Idoven 1903 S.L.
Hol
Hollandia és Spanyolország13 helyszín, 2 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
5342 fő, tervezett
Kezdés
2023. ápr. 4.
Várható befejezés
2026. dec.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • AI-powered ECG analysis to detect cardiac arrhythmic episodes
A regiszteradat frissítve
2026. november 6.

Ki vehet részt

Életkor
4 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient presenting relevant cardiac arrhythmias and cardiac patterns (including supraventricular tachycardias, abnormal ECG patterns, ventricular tachycardias, ventricular fibrillation, pulseless electrical activity or asystole among others) that have been recorded with at least one short-term ECG medical device according to guidelines with ≥1 signal-channel
  • Patient with suspected or diagnosed acute/chronic cardiac diseases (including patients with heart failure, patients with history of cardiac arrhythmias, patients with probable coronary artery diseases, patients with cardiomyopathies, patients with pacemakers or implantable cardioverter-defibrillators (ICD), patients with indication of pacemaker or ICD in current or short-term phase, patients participating in other interventional clinical investigation, patients with hemodynamic instability or acute coronary syndromes, pregnant patients, patients with cancer and chemotherapy, patients with life-expectancy lower than 24 months, patients with in or out-of-hospital cardiac arrest with ventricular fibrillation as first documented rhythm)
  • At least one ECG tracing that can be exported in raw data
  • Signed informed consent. Patients unable to consent, it will be requested to an authorized relative

Ki nem vehet részt

  • Unwillingness or inability to sign study written informed consent
  • Unavailable or suboptimal quality of the electrocardiographic signal in raw data

Ez a vizsgálat jelenleg itt érhető el: Spanyolország.

2 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

WILLEM is a multi-center, prospective and retrospective cohort study.

A teljes eredeti leírásKevesebb

The study will assess the performance of a cloud-based and AI-powered ECG analysis platform, named Willem™, developed to detect arrhythmias and other abnormal cardiac patterns. The main questions it aims to answer are:

1. A new AI-powered ECG analysis platform can automatice the classification and prediction of cardiac arrhythmic episodes at a cardiologist level. 2. This AI-powered ECG analysis can delay or even avoid harmful therapies and severe cardiac adverse events such as sudden death.

The prerequisites for inclusion of patients will be the availability of at least one ECG record in raw data, along with patient clinical data and evolution data after more than 1-year follow-up.

Cardiac electrical signals from multiple medical devices will be collected by cardiology experts after obtaining the informed consent. Every cardiac electrical signal from every subject will be reviewed by a board-certified cardiologist to label the arrhythmias and patterns recorded in those tracings. In order to obtain tracings of relevant information, >95% of the subjects enrolled will have rhythm disorders or abnormal ECG's patterns at the time of enrollment.

A vizsgálat 2 csoportja

  • Train group

    Consecutive patients admitted to the hospital due to cardiac disorders (retrospective and prospective) with at least one relevant ECG record \>10 sec in raw data will be used to design new methodologies and algorithms for cardiac patterns recognition.

    Kezelés: AI-powered ECG analysis to detect cardiac arrhythmic episodes

  • Test group

    Consecutive patients admitted to the hospital due to cardiac disorders (retrospective and prospective) with at least one relevant ECG record \>10 sec in raw data will be used to evaluate performance of methodologies aiming to avoid overfitting. Every 10 patients included in Train group; a new patient is included in the test group.

    Kezelés: AI-powered ECG analysis to detect cardiac arrhythmic episodes

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Evaluation of Electrocardiographic Data From High-risk Cardiac Patients Using Willem™ Cardiologist-level Artificial Intelligence Software. WILLEM Trial.
A regiszteradat frissítve
2026. november 6.